LEAD MATERIAL SPECIALIST Sample Clauses

LEAD MATERIAL SPECIALIST a. A Lead Material Specialist is a working member of the group who must meet all of the requirements of a Material Specialist. In addition, a Lead Material Specialist must be able to lead and direct the work of all Material Specialists on his shift. Whenever possible, a Lead Material Specialist shall communicate the status of assigned work to the Supervisor. The Lead Material Specialist shall also assist Supervisors with the assignment and coordination of on the job training.
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
LEAD MATERIAL SPECIALIST. (6087) In the absence of appropriate supervision and when directed, leads, assists, and works with other departmental personnel to ensure the efficient operation of related activities. May be required to develop schedules, direct work assignments, prepare job related reports, complete other administrative duties, function in a Journeyman capacity, and perform other work as needed. Employees will perform any and all tasks for which they are properly trained and can competently and safely perform. 6087 Lead Material Specialist 1 $37.03 $37.77 $38.53 MATERIAL SPECIALIST (6088) Performs any and all warehouse inventory functions in order to maintain and operate the warehouse. This includes but is not limited to manual and clerical duties in conjunction with receiving, storing, returns, transfers, picking, staging and issuing supplies, tools, and equipment; unloads and unpacks incoming materials; places, shelves and racks stock of machine, hand and construction tools; measures, counts, cuts, creates, marks and stencils materials, supplies, tools and equipment; keeps the premises clean; operate vehicles as required to execute assigned tasks (including deliveries, purchases, etc.). All Material Specialists must have and maintain a Class A Commercial Drivers’ License (CDL) in the State of Nevada. The Company will be responsible for the cost of any physical and license renewal fees. Operates special pole yard cranes to receive, load and unload poles, large transformer and cable reels, switches and other heavy equipment, and determines location and reordering of same. Operates forklifts and various material handling equipment. Supervises the orderly accumulation, and removal of scrap materials. 6088 Material Specialist 1 $31.16 $31.78 $32.42 2nd Six Months 2 $32.32 $32.97 $33.63 3rd Six Months 3 $34.18 $34.86 $35.56 -156- NV Energy - IBEW L396 Collective Bargaining Agreement 09/24/2013-08/31/2017 A ALTERNATIVE, 30, 49, 57, 65, 110 ALTERNATIVE SHIFTS, 15, 71, 80, 114, 119, 122, 143 AMENDMENT, 4, 51, 54 APPLICATION REFERRAL, 10 APPRENTICE, 51, 85 ASSIGNMENT TO AN ESTABLISHED SCHEDULE, 19 B BANKED HOLIDAYS, 29, 116, 124 BENEFIT, 3, 11, 12, 13, 33, 35, 36, 39, 41 BENEFITS, 8, 9, 10, 11, 12, 24, 29, 33, 34,35, 36, 37, 38, 39, 40, 41, 42, 43, 46, 48, 50, 57, 58, 50, 60, 61, 63, 143 BOARD AND LODGING, 20 BREAK PERIOD, 15, 81, 111, 115, 122 bridged time for re-hired employees, 24, 44 BULLETIN BOARDS, 7 BUSINESS MANAGEMENT, 6 C CALL-OUTS, 16, 66, 81, 82, 111, 112, 113, 115, 1...
Sample 1

Related to LEAD MATERIAL SPECIALIST

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials, and other studies (collectively, “studies”) that are described in, or the results of which are referred to in, the Registration Statement or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with the protocols, procedures and controls designed and approved for such studies and with standard medical and scientific research procedures; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement or the Prospectus; the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by the Food and Drug Administration of the U.S. Department of Health and Human Services or any committee thereof or from any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies”); neither the Company nor any of its subsidiaries has received any notice of, or correspondence from, any Regulatory Agency requiring the termination, suspension or modification of any clinical trials that are described or referred to in the Registration Statement or the Prospectus; and the Company and its subsidiaries have each operated and currently are in compliance in all material respects with all applicable rules, regulations and policies of the Regulatory Agencies.

  • Research Analyst Independence The Company acknowledges that the Underwriters’ research analysts and research departments are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such Underwriters’ research analysts may hold views and make statements or investment recommendations and/or publish research reports with respect to the Company and/or the offering that differ from the views of their respective investment banking divisions. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against the Underwriters with respect to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriters’ investment banking divisions. The Company acknowledges that each of the Underwriters is a full service securities firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short positions in debt or equity securities of the companies that may be the subject of the transactions contemplated by this Agreement.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!